As of Oct 21
| +0.05 / +1.69%|
The 4 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 3.63, with a high estimate of 5.00 and a low estimate of 2.75. The median estimate represents a +20.43% increase from the last price of 3.01.
The current consensus among 4 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.